Purification of PEGylated protein using membrane chromatography

Journal of Pharmaceutical Sciences

Volumn 99, Issue 8, 2010, Pages 3326-3333

  Yu, Deqiang ^a   Ghosh, Raja ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Biotechnology; Chromatography; PEGylation; Proteins; Separation science

Indexed keywords

LYSOZYME; ARTIFICIAL MEMBRANE; MACROGOL DERIVATIVE; PROTEIN;

ARTICLE; BINDING AFFINITY; ION EXCHANGE CHROMATOGRAPHY; MEMBRANE BINDING; MEMBRANE CHROMATOGRAPHY; PROTEIN BINDING; PROTEIN PURIFICATION; ARTIFICIAL MEMBRANE; CALIBRATION; CHEMISTRY; GEL CHROMATOGRAPHY; ISOLATION AND PURIFICATION; MOLECULAR WEIGHT; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRESSURE;

CALIBRATION; CHROMATOGRAPHY, GEL; CHROMATOGRAPHY, ION EXCHANGE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; MEMBRANES, ARTIFICIAL; MOLECULAR WEIGHT; MURAMIDASE; POLYETHYLENE GLYCOLS; PRESSURE; PROTEINS;

EID: 77955111992     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.22103     Document Type: Article

References (29)

1. Reddy KR, Modi MW, Pedder S. 2002. Use of peginterferon alfa-2a (40KD) (Pegasys®) for the treatment of hepatitis C. Adv Drug Deliv Rev 54:571-586. (Pubitemid 34615548)
2. Wang YS, Youngster S, Grace M, Bausch J, Bordens R, Wyss DF. 2002. Structural and biological characterization of pegylated recombinant interferon alpha-2b and its therapeutic implications. Adv Drug Deliv Rev 54:547-570.
3. Kinstler O, Molineux G, Treuheit M, Ladd D, Gegg C. 2002. Mono-N-terminal poly(ethylene glycol)-protein conjugates. Adv Drug Deliv Rev 54:477-485.
4. Roberts MJ, Bentley MD, Harris JM. 2002. Chemistry for peptide and protein PEGylation. Adv Drug Deliv Rev 54:459-476.
5. Chapman AP, Antoniw P, Spitali M, West S, Stephens S, King DJ. 1999. Therapeutic antibody fragments with prolonged in vivo half-lives. Nat Biotechnol 17:780-783.
6. DeFrees S, Wang ZG, Xing R, Scott AE, Wang J, Zopf D, Gouty DL, Sjoberg ER, Panneerselvam K, Brinkman-Van der Linden EC, Bayer RJ, Tarp MA, Clausen H. 2006. GlycoPEGylation of recombinant therapeutic proteins produced in Escherichia coli. Glycobiology 16:833-843.
7. Chen T, Small DA, Wu L, Rubloff GW, Ghodssi R, Vazquez-Duhalt R. 2003. Nature-inspired creation of proteinpolysaccharide conjugate and its subsequent assembly onto a patterned surface. Langmuir 19:9382-9386.
8. Shaunak S, Godwin A, Choi J, Balan S, Pedone E, Vijayarangam D, Heidelberger S, Teo I, Zloh M, Brocchini S. 2006. Sitespecific PEGylation of native disulfide bonds in therapeutic proteins. Nat Chem Bio 2:312-313. (Pubitemid 43787211)
9. Wong. SS. 1991. Reactive groups of proteins and their modifying agents in: Chemistry of Protein Conjugation and Crosslinking. Boston: CRC Press. p 13.
10. Hermanson GT. 1996. Bioconjugation techniques. London: Academic Press. p 141.
11. Lee H, Jang H, Ryu SH, Park TG. 2003. N-Terminal sitespecific mono-PEGylation of epidermal growth factor. Pharm Res 20:818-825. (Pubitemid 36515317)
12. Dou H, Zheng M, Zhang Y, Yin C. 2007. Synthesis and purification of mono-PEGylated insulin. Chem Biol Drug Des 69:132-138.
13. Basu A, Yang K, Wang M, Liu S, Chintala R, Palm T, Zhao H, Peng P,Wu D, Zhang Z, Hua J, Hsieh MC, Zhou J, Petti G, Li X, Janjua A, Mendez M, Liu J, Longley C, Zhang Z, Mehlig M, Borowski V, Viswanathan M, Filpula D. 2006. Structure-function engineering of interferon-α1b for improving stability, solubility, potency, immunogenicity, and pharmacokinetic properties by site-selective mono-PEGylation. Bioconjugate Chem 17:618-630.
14. Kinstler OB. 2005. N-terminally chemically modified protein compositions and methods. US Patent US 6956027,Amgen.
15. Yun Q, Yang RE, Chen T, Bi J, Ma G, Su Z. 2005. Reproducible preparation and effective separation of PEGylated recombinant human granulocyte colony-sitmulating factor with novel "PEG-pellet" PEGylation mode and ion-exchange chromatography. J Biotechnol 118:67-74.
16. Piquet G, Gatti M, Barbero L, Traversa S, Caccia P, Esposito P. 2002. Set-up of large laboratory-scale chromatographic separations of poly (ethylene glycol) derivatives of the growth hormone-releasing factor1-29 analogue. J Chromatogr A 944:141-148.
17. Foser S, Schacher A, Weyer KA, Brugger D, Dietel E, Marti S, Thomas Schreitmuller T. 2003. Isolation, structural characterization, and antiviral activity of positional isomers of monopegylated interferon α-2a (PEGASYS). Protein Expr Purif 30:78-87.
18. Pabst TM, Buckley JJ, Ramasubramanyan N, Hunter AK. 2007. Comparison of strong anion-exchangers for the purification of a PEGylated protein. J Chromatogr A 1147:172-182. (Pubitemid 46466833)
19. Fee CJ, Van Alstine JM. 2006. PEG-proteins: Reaction engineering and separation issues. Chem Eng Sci 61:924-939.
20. Hall T, Wood DC, Smith CE. 2004. Preparative and analytical chromatography of pegylated myelopoietin using monolithic media. J Chromatogr A 1041:87-93.
21. Ghosh R. 2002. Protein separation using membrane chromatography: Opportunities and challenges. J Chromatogr A 952:13-27.
22. Knudsen HL, Fahrner RL, Xu Y, Norling LA, Blank GS. 2001. Membrane ion-exchange chromatography for process-scale antibody purification. J Chromatogr A 907:145-154. (Pubitemid 33648404)
23. Phillips M, Cormier J, Ferrence J, Dowd C, Kiss R, Lutz H, Carter J. 2005. Performance of a membrane adsorber for trace impurity removal in biotechnology manufacturing. J Chromatogr A 1078:74-82.
24. Fee CJ, Van Alstine JM. 2004. Prediction of the viscosity radius and the size exclusion chromatography behavior of PEGylated proteins. Bioconjug Chem 15:1304-1313.
25. Hagel L. 1998. Gel filtration. In: Janson JC, Ryden L, editors. Protein purification. 2nd edition. New York: John Wiley & Sons. p 93.
26. Kuga S. 1981. Pore size distribution analysis of gel substances by size exclusion chromatography. J Chromatogr 206:449-461.
27. Ghosh R, Wong T. 2006. Effect of module design on the efficiency of membrane chromatographic separation processes. J Membr Sci 281:532-540.
28. Laemmli UK. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
29. Kurfurst MM. 1992. Detection and molecular weight determination of polyethylene glycol-modified hirudin by staining after sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Anal Biochem 200:244-248.